This completely new line of separation instrumentation and software was designed for the widest range of analytes including proteins, polymers, viruses, gene vectors, liposomal drug nanoparticles, and more. Covering a range of sizes from 1 nm to 10 µm, the Eclipse offers programmable separation power for enhanced resolution within any size range. The system incorporates sophisticated micro-controllers and sensors with built-in intelligence and an intuitive interface to ensure simple use, reliability and repeatability across research, development and quality control environments.

The introduction of Mobility™ implements electrical/asymmetric-flow FFF for determining size-resolved zeta potential. The new Dilution Control Module™ (DCM) increases sample concentrations up to 10x, for higher sensitivity and fraction titer. Improved channel design provides unique and accurate temperature control for higher sample recovery, reproducibility and pressure stability.

Geofrey Wyatt, CEO of Wyatt Technology, said, “To say that I’m proud of the accomplishments of Team Wyatt in developing the new Eclipse...

Developing reliable means of separation and characterization methods is just one more way that Wyatt Technology fulfills its mission: to help ensure our customers’ success in providing leading-edge, life-enhancing products.

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!